- Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
- ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
- ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE
- Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
- Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
- Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
More ▼
Key statistics
On Friday, Enzo Biochem Inc (ENZ:NYQ) closed at 1.16, 17.16% above the 52 week low of 0.9901 set on May 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.24 |
---|---|
High | 1.24 |
Low | 1.08 |
Bid | 1.05 |
Offer | 1.26 |
Previous close | 1.13 |
Average volume | 83.85k |
---|---|
Shares outstanding | 51.23m |
Free float | 38.60m |
P/E (TTM) | -- |
Market cap | 59.42m USD |
EPS (TTM) | -0.3516 USD |
Data delayed at least 15 minutes, as of Jun 15 2024 00:00 BST.
More ▼